A global polio resurgence and the need to reevaluate the basics

The resurgence of polio worldwide, including the detection of both wild poliovirus (WPV) and vaccine-derived poliovirus (VDPV), raises critical questions about the current approaches to polio eradication. The article highlights two key issues: the challenges in controlling polio, and the ongoing debate regarding the effectiveness of Oral Polio Vaccine (OPV) versus Inactivated Polio Vaccine (IPV) in eradicating the disease.

1. Resurgence of Polio: A Global Concern

The World Health Organization (WHO) reports that poliovirus has been detected in environmental samples from countries such as Finland, Germany, Poland, Spain, and the United Kingdom. While no cases have yet been confirmed in these regions, the presence of the virus in wastewater underscores the global nature of the polio threat. Even in countries with high immunization rates (85-95%), pockets of undervaccination and gaps in immunity exist. This can lead to the continued circulation of poliovirus, especially vaccine-derived strains.

• Vaccine-derived poliovirus (cVDPV) is a consequence of using OPV, a live-attenuated vaccine. Though OPV is highly effective in controlling polio, it can, in rare cases, mutate in the gut of vaccinated individuals and spread in under-immunized populations. In certain circumstances, this mutated virus can lead to outbreaks of vaccine-derived polio.
• The resurgence of cVDPV and environmental samples testing positive for poliovirus in regions with high vaccination coverage emphasize that even strong immunization campaigns must be supplemented with rigorous surveillance and targeted vaccination programs. This highlights a critical need for ongoing vigilance and intervention, even in nations where polio was previously considered eradicated.

2. Vaccination Challenges: OPV vs IPV

The main debate in the article revolves around the use of OPV versus IPV in global polio eradication efforts:

• OPV (Oral Polio Vaccine): This live-attenuated vaccine has been a cornerstone of polio eradication. OPV is easy to administer, cost-effective, and has led to the significant reduction of polio cases worldwide. However, a key downside of OPV is that it can lead to the development of vaccine-derived poliovirus (VDPV), as the weakened virus can revert to a virulent form in the gut and spread within under-immunized populations.
• IPV (Inactivated Polio Vaccine): Unlike OPV, IPV is an inactivated, non-transmissible vaccine. It does not carry the risk of generating VDPVs because it does not replicate in the human gut. IPV has been recognized as safer in the long run, as it reduces the potential for the virus to mutate and spread. However, it is more expensive, requires more complex logistics, and is less effective in providing herd immunity compared to OPV.

3. Shifting from OPV to IPV

Given the risks of VDPVs with OPV, some experts, including Dr. Jacob John, advocate for a global switch from OPV to IPV as the preferred approach for polio eradication. Dr. John emphasizes that OPV is not suitable for polio eradication and should only be used for polio control. He argues that IPV, being non-transmissible, will expedite the elimination of wild poliovirus (WPV) and circulating vaccine-derived poliovirus (cVDPV).

The article discusses how the shift from OPV to IPV could be implemented gradually, country by country, until OPV is no longer used anywhere in the world. This transition is essential to avoid the paradox where polio is eradicated in the name of vaccination but continues to exist as a vaccine-derived strain.

4. Transmission Route: Faecal-Oral vs. Respiratory

The article also touches upon the transmission route of poliovirus, which has been traditionally understood as primarily faecal-oral. This means the virus is transmitted through contaminated water or food, typically in regions with poor sanitation.

However, Dr. Jacob John and others argue that respiratory transmission may be a significant, though often overlooked, pathway for poliovirus. Their research suggests that poliovirus shedding in the throat plays a key role in its transmission. This would imply that the standard assumption of faecal-oral transmission might not fully explain outbreaks, and that respiratory transmission might be more significant than previously thought.

If this hypothesis is correct, then the widespread use of OPV, which targets the faecal-oral route, may not be as effective in addressing respiratory transmission. IPV, which does not rely on virus replication in the gut, might therefore offer a more robust defense against both routes of transmission.

5. Surveillance and Immunization Gaps

Despite high immunization coverage in many countries, pockets of undervaccination persist. The WHO and national health authorities are closely monitoring immunity gaps through ongoing disease surveillance. This includes checking for potential subnational immunity gaps and conducting investigations when the virus is detected in environmental samples. The detection of polio in Gaza in 2024 highlights the importance of maintaining high vaccination rates and robust disease surveillance, especially in conflict zones where health systems are weakened.

Even in countries with strong vaccination programs, some individuals remain unvaccinated due to logistical challenges, misinformation, or lack of access. Addressing these gaps is crucial for achieving global polio eradication.

Conclusion:

The resurgence of polio, particularly in the form of vaccine-derived polioviruses, signals that the battle against polio is not over. The debate between OPV and IPV highlights the complexities involved in polio eradication. While OPV has been instrumental in reducing polio cases, the risks associated with vaccine-derived strains emphasize the need for a global shift toward IPV. At the same time, the ongoing surveillance of poliovirus in wastewater and immunization gaps underscores the importance of vigilance in maintaining high vaccination coverage worldwide.

The Global Polio Eradication Initiative (GPEI) must continue adapting its strategies to prevent polio, moving away from OPV where appropriate and implementing IPV to close immunity gaps and eradicate both wild and vaccine-derived poliovirus. Global collaboration, strong surveillance, and addressing undervaccination are key to ensuring that the world remains on track for polio eradication.

Mains Question and Answer

In light of the recent resurgence of polio and the debate between Oral Polio Vaccine (OPV) and Inactivated Polio Vaccine (IPV), critically analyze the effectiveness of current polio eradication strategies. What changes are required to ensure global eradication of polio, and how can countries address the issues of vaccine-derived poliovirus (VDPV) and undervaccination?

Answer:

The resurgence of polio globally, particularly in the form of vaccine-derived poliovirus (VDPV), raises significant concerns regarding the current strategies for polio eradication. Despite high vaccination rates and substantial efforts, poliovirus continues to pose a threat in several regions. This resurgence is partly attributed to the limitations of the Oral Polio Vaccine (OPV), which, while effective in reducing the transmission of wild poliovirus (WPV), can lead to mutations that cause VDPV. The presence of VDPVs in environmental samples in countries with high immunization rates, such as Finland, Germany, and the United Kingdom, further underscores the urgency of reevaluating existing vaccination practices.

Current Challenges in Polio Eradication:

1.     Vaccine-Derived Poliovirus (VDPV): The use of OPV, a live-attenuated vaccine, has contributed to the spread of VDPV in under-immunized populations. Although OPV is highly effective in areas with limited healthcare infrastructure, its ability to mutate and revert to a virulent form in the gut poses a risk in countries with high vaccination coverage but pockets of undervaccination. These mutations can lead to outbreaks of polio, as seen in countries like Nigeria, Chad, and Cameroon. This paradox — where a vaccine intended to eradicate polio ends up causing it — complicates global efforts to eliminate the disease.

2.     Undervaccination and Immunity Gaps: Even in countries with strong routine immunization programs, pockets of undervaccination remain. Factors such as logistical challenges, political instability, misinformation, and lack of access to healthcare contribute to incomplete vaccination coverage. These gaps leave vulnerable populations exposed to poliovirus outbreaks, even if the majority of the population is immunized. Surveillance has revealed that the virus persists in the environment, often in sewage systems, highlighting the need for continued vigilance and targeted vaccination efforts.

3.     Global Surveillance and Monitoring: The WHO’s detection of polio in environmental samples from countries in Europe, along with confirmed cases in regions like Gaza, indicates that polio is no longer confined to traditionally endemic areas. Surveillance systems must be strengthened globally to detect and track the presence of the virus in both environmental samples and human cases. Countries with advanced healthcare systems must remain vigilant in ensuring high vaccination rates to prevent the reemergence of polio, while also addressing local immunization gaps.

Recommendations for Global Polio Eradication:

1.     Switch from OPV to IPV: The most significant change required to address the VDPV issue is the gradual transition from OPV to IPV. While OPV has been critical in reducing WPV, IPV is a non-transmissible vaccine that carries no risk of VDPV. IPV’s safety and effectiveness in preventing paralysis without the risk of environmental transmission make it the preferred option for the final stages of polio eradication. The Global Polio Eradication Initiative (GPEI) must prioritize the implementation of IPV worldwide, with a phased switch from OPV to IPV country by country.

2.     Addressing Undervaccination and Immunization Gaps: To ensure the success of the eradication efforts, it is essential to address the undervaccination issue. Governments and international organizations must focus on ensuring universal access to vaccination, particularly in remote and underserved areas. Additionally, targeted immunization campaigns must be conducted in regions with suboptimal vaccination coverage, including in conflict zones, refugee camps, and areas with logistical challenges.

3.     Strengthening Surveillance Systems: Surveillance of both environmental samples and human cases must be strengthened globally. Detecting the presence of poliovirus in sewage systems or wastewater treatment plants, as demonstrated by the detection of poliovirus in European countries, is a valuable tool for early intervention. Countries should also enhance monitoring systems for immune coverage and address any subnational immunity gaps to ensure that there are no vulnerable populations left unprotected.

4.     Public Awareness and Misinformation Management: The success of polio eradication efforts also depends on combating misinformation about vaccines. Public awareness campaigns must be intensified, especially in areas where vaccine hesitancy is a concern. Health authorities should work to build trust in vaccination programs through education and transparent communication, dispelling myths about vaccine safety and efficacy.

5.     Global Collaboration and Funding: The eradication of polio is a global public health priority that requires strong international collaboration. Governments, the WHO, the United Nations, and private organizations such as Gavi must continue to work together to provide the necessary funding and logistical support for immunization campaigns. The global community must also be prepared to support countries with weaker healthcare systems, ensuring that no nation is left behind in the fight against polio.

Conclusion:

Polio eradication efforts have made remarkable strides over the past few decades, but the emergence of vaccine-derived poliovirus and the persistence of immunization gaps have highlighted the need for a renewed focus on the basics of vaccination. The global switch from OPV to IPV, along with strengthened surveillance, targeted vaccination campaigns, and increased public awareness, is crucial for achieving complete eradication of polio. The lessons learned from the current resurgence of polio should serve as a reminder that vigilance and adaptation are essential to ensuring that polio does not return to the global stage.

The Global Polio Eradication Initiative can succeed only if the global community works together to eliminate immunization gaps, improve surveillance systems, and transition to safer vaccines that can guarantee a polio-free future for all.